$ 16.14
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of KMTS is 27 and suggests 68% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
